Human Recombinant DNA: Global Markets
Report Scope:
This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, trends and key players in the market. The report also provides market projections from 2022 through 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, and market forces are also provided.
Report Includes:
24 data tables and 8 additional tables
An overview of the global market for human recombinant DNA
Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
Highlights of the market potential for human recombinant DNA, based on product, application, and region
Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Company profiles of major players within the industry AbbVie Inc., Amgen Inc., Eli Lilly, Sanofi
- Chapter 1 Introduction
- Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Intended Audience
- Scope and Format
- Methodology
- Market Estimates
- Information Sources
- Geographical Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Overview
- Homologous Recombination (HR)
- Targets for Cancer Therapy
- Chapter 4 Impact of COVID-19 Pandemic
- Chapter 5 Market Dynamics
- Market Drivers
- Increasing Incidences of Chronic Diseases
- Growing Aging Population
- Advancements in Manufacturing Technologies
- Market Restraints
- Price Controls
- Entry of Biosimilars
- Opportunities
- Untapped Potential in Emerging Markets
- Chapter 6 Market Breakdown by Product Type
- Human Protein Replacements
- Market Size and Forecast
- Therapeutic Agents for Human Diseases
- Market Size and Forecast
- Vaccines
- Types of Vaccines
- Market Size and Forecast
- Chapter 7 Market Breakdown by End User
- Biotechnology and Pharmaceutical Industry
- Market Size and Forecast
- Research Laboratories and Academic Institutes
- Market Size and Forecast
- Chapter 8 Market Breakdown by Region
- Global Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 9 Competitive Landscape
- Overview
- Chapter 10 Company Profiles
- ABBVIE INC.
- ALEXION PHARMACEUTICALS
- AMGEN INC.
- ELI LILLY
- MERCK & CO. INC.
- SANOFI S.A.
- TAKEDA PHARMACEUTICAL CO LTD.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook